+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

(-)-Hydroxycitric acid

BP2390
27750-10-3
98%
Phytopurify
(-)-Hydroxycitric acid (HCA) can inhibit fat synthesis and reduces food intake, the primary mechanism of action of HCA appears to be related to its ability to act as a competitive inhibitor of the enzyme ATP-citrate lyase, which catalyzes the conversion of citrate and coenzyme A to oxaloacetate and acetyl coenzyme A (acetyl-CoA), primary building blocks of fatty acid and cholesterol synthesis. Hydroxycitric acid ameliorates high-fructose-induced redox imbalance and activation of stress sensitive kinases in male Wistar rats through its hypolipidemic effects.
Catalog No Package Original Price Price Inventory Quantity Operating
BP2390-20mg 20mg
BP2390-100mg 100mg
BP2390-1000mg 1000mg
Chengdu Biopurify Phytochemicals Ltd.
Chengdu Biopurify Phytochemicals Ltd.

Related diseases

Related targets

SREBF1 FASN LEP ADIPOQ PPARA

(-)-Hydroxycitric acid Related Products

Product drug property prediction parameters

  • 152.3600

  • -1.1996

  • -2.7720

  • 110.0125

  • .4168

  • .5982

  • Low

  • 30.9513

  • 3.3982

  • Yes

  • No

  • No

  • No

  • No

  • No

  • 0.0

  • Yes

  • Yes

  • Yes

  • Yes